documents: FDA-2006-N-0515-0082

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2006-N-0515-0082 FDA FDA-2006-N-0515 Reference 13 - FDA, "Guidance for industry, M3 (R2) Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals and the International Conference on Harmonisation S5 (R2) Guideline: Detection of Toxicity to Reproduction for Medicinal Products and Toxicity to Male Fertility,". re Content and Format of Labeling for Human Prescription Drug Supporting & Related Material Background Material 2014-12-05T05:00:00Z 2014 12     2014-12-05T14:49:22Z   0 0 090000648195b8e3

Links from other tables